Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 2 May 2006
Vol. 2006, Issue 333, p. tw150
[DOI: 10.1126/stke.3332006tw150]

EDITORS' CHOICE

PHARMACOLOGY Botox Receptor

Botulinum neurotoxin A (BoNT/A) is one of seven neurotoxins produced by the bacterium Clostridium botulinum. BoNT/A has a long half-life within cells and is widely used in the treatment of conditions ranging from wrinkles to chronic pain. Moreover, BoNT/A can cause paralysis that persists for months. BoNT/A is known to block neurotransmission by cleaving the protein SNAP-25 in presynaptic terminals, but it is not clear how this toxin selectively recognizes and enters neurons. Dong et al. now identify a protein component of the cellular receptor for BoNT/A as a synaptic vesicle protein, SV2. BoNT/A enters neurons via recycling synaptic vesicles by binding to SV2 isoforms, and cells and animals lacking SV2 are resistant to intoxication.

M. Dong, F. Yeh, W. H. Tepp, C. Dean, E. A. Johnson, R. Janz, E. R. Chapman, SV2 is the protein receptor for botulinum neurotoxin A. Science 312, 592-596 (2006). [Abstract] [Full Text]

Citation: Botox Receptor. Sci. STKE 2006, tw150 (2006).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882